# INTERVIEW: Widecells Group to produce Stem Cells from Adults

- Link: https://www.directorstalkinterviews.com/interview-widecells-group-produce-stem-cells-adults/412747583
- Published: 2018-03-19T09:44:41+00:00
- Author: Giles Arbor

**Widecells Group plc** (LON:WDC) CEO João Andrade and CSO Peter Hollands talk to
DirectorsTalk about a government-backed Innovate UK Knowledge Transfer Partnership
with Manchester Metropolitan University (MMU) to undertake research on a new form
of stem cell technology. In this interview we discuss how the research side fits
in withe the business, explain what this new research project is, who Innovate UK
are, their involvement, the potential of these new types of stem cells and once 
commercialised how this will affect the business.

WideCells Group PLC is building an integrated stem cell services company, focused
on making stem cell treatments accessible and affordable. This is achieved through
three divisions. CellPlan: the world’s first stem cell healthcare insurance plan
with financial cover for medical treatment, travel and accommodation expenses and
concierge service to manage the treatment process. WideCells: The Institute of Stem
Cell Technology has been established and is based in the University of Manchester
Innovation Centre to focus on stem cell research and regenerative medicine. WideCells
also has international cryogenics divisions specialising in stem cell storage. Wideacademy:
an education and training division to promote awareness of the benefits of stem 
cell storage across the global general practice community.

The Group has built an experienced senior management team that has been integral
to the development of its growth and business to date.

Share on: